Answers are grounded in this paper and cite their sources.
Despite abundant evidence demonstrating the benefits of continuous glucose monitoring (CGM) in diabetes management, a significant proportion of people using this technology still struggle to achieve glycemic targets. To address this challenge, we propose the Accu-Chek
No takes yet. Share an insight, caveat, or question.
Herrero et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: